Volumetric Pumps Market Size, Share, Growth, and Industry Growth by Type (JDREX, PVM, MONO, ING and Other) By Application (Chemical, Industrial, Winemaking and Other), Regional Forecast To 2035

Last Updated: 12 September 2025
SKU ID: 21170679

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

VOLUMETRIC PUMPS MARKET OVERVIEW

The global volumetric pumps market was valued at USD 3.13 billion in 2025 and is expected to grow to USD 3.31 billion in 2026, reaching USD 5.51 billion by 2035, with a projected CAGR of 5.8% during the forecast period.

Volumetric pumps are medical devices that can continuously give very precise fluid dosages at rates ranging from very slow to very fast. To regulate the flow of intravascular medications, fluids, whole blood, and blood products to patients, infusion pumps are frequently utilized. The majority of volumetric pumps operate using one of two versatile devices: a spinning or countering mechanism. Positive dislocation pumps are used by engineers for systems requiring pressured fluids, particularly in the chemical industry. Yet, you can discover these pumps in little factories and workshops. Engine injection systems are undoubtedly another type of positive displacement pump. Conservative piston or nozzle pumps are used as positive pumps in this modality.  

KEY FINDINGS

  • Market Size and Growth: Valued at USD 3.13 billion in 2025, expected to reach USD 5.51 billion by 2035, growing at a CAGR 5.8%.
  • Key Market Driver: Home/alternate-site infusion now represents roughly ~16% (home) plus ~4% (alternate sites) of infusion volume — shifting demand.
  • Major Market Restraint: Stricter regulations and recalls constrain growth, but no reliable percentage quantifying regulatory impact is publicly reported.
  • Emerging Trends: Ambulatory/home infusion share of total infusion settings is rising — home infusions ≈ 16% of infusions today.
  • Regional Leadership: North America held about 38.6% of the overall infusion-pump market in 2023.
  • Competitive Landscape: Top infusion-pump manufacturers dominate the market; however, no aggregate percentage for top-5 concentration specific to volumetric pumps is publicly reported.
  • Market Segmentation (JDREX, PVM, MONO, ING): MONO is expected to dominate, but no public percentage splits for JDREX/PVM/MONO/ING are available.
  • Recent Development: Volumetric segment share estimates vary — examples: 16.8%, 28.2%, 32% reported for different datasets/years.

COVID-19 IMPACT

Increased COVID-19 Infection Disease Management Need Will Boost Market Opportunities  

The COVID-19 pandemic's effects and the uncertainty surrounding its longevity have caused a significant increase in the industry's growth rate. This is primarily because to the rise of COVID-19 testing. The COVID-19 pandemic did cause a decrease in production, nonetheless, as a result of staff shortages and supply chain interruptions. For instance, the demand for specific healthcare products, such as volumetric pumps, has fluctuated significantly and unpredictably during the COVID-19 pandemic.  

LATEST TRENDS

Expanding R&D Initiatives to Introduce Home Infusion Systems to Expand Market 

Growing research and development efforts are being made to create home-based infusion products as a result of the rising prevalence of chronic diseases and the rising expense of hospital-based infusion therapies. For instance, an increasing number of people with diabetes, cancer, and neurological disorders need long-term care, ideally at home. The need for long-term care therapies among an ageing population is another factor driving the creation of new products aimed at home-based infusion therapies. The market's top players are concentrating on site of care administration for specialty drugs. The Epic smart volumetric pump was created by Ivenix, Inc. to help reduce patient damage caused by intravenous infusions.

  • From 2005 through 2009 there were approximately 56,000 reports of adverse events related to infusion pumps (which include volumetric pumps), many involving software defects, user interface issues, or mechanical/electrical failures.
  • About 590 million adults aged 20‑79 years are living with diabetes globally, and over 40% of these are unaware that they have the condition. 
Global-Volumetric-Pumps-Market-Share,-By-Type,-2035

ask for customizationRequest a Free sample to learn more about this report

VOLUMETRIC PUMPS MARKET SEGMENTATION

By Type Analysis

By type, the volumetric pumps market is segmented into jdrex, pvm, mono, ing and other.  

The mono type of segment will dominate the volumetric pumps market in the coming years. 

By Application Analysis

Based on applications, the volumetric pumps market is chemical, industrial, winemaking, and other.  

The industrial segment will lead the global share through forecast period. 

DRIVING FACTORS

Ambulatory Pump Demand is Increasing, Driving Market Growth

An important tool for drug delivery in a variety of medical settings is the ambulatory pump. They are essential in giving patients analgesics, chemotherapy, TPN infusions, and other treatments in hospitals and at home. The need for volumetric pumps is projected to rise in the near future in developed countries as the management of chronic diseases is moved to the site of care to reduce the financial burdens associated with hospital-based management.

  • The global population of individuals with diabetes increased from 200 million in 1990 to 830 million in 2022.
  • Between 2021 and 2023, 15.8% of adults in the U.S. had diabetes, including 11.3% diagnosed cases and 4.5% undiagnosed cases.

Chronic Diseases are Becoming More Common, Pushing Market Growth

Volumetric pumps offer significant benefits over manual fluid administration, including the ability to give fluids at precise programmed rates and in very small dosages. These pumps are frequently used to deliver medicine to keep drug levels in the bloodstream stable in conditions like cancer and diabetes. Insulin devices are becoming more and more popular for managing type 1 diabetes. To accomplish continuous medication delivery for these individuals, user-friendly self-controlled pumps are required. All of these elements working together are accelerating the development for volumetric pumps market worldwide.

RESTRAINING FACTORS

The Production of Pumps is Subject to Strict Regulations that Limit Market Expansion

Regulations governing the manufacture and use of pumps are becoming more onerous, which slows down the approval process for new goods. This factor is expected to slow market expansion. The volumetric pumps market development is also being constrained by an increase in product recalls brought on by manufacturing mistakes. 

  • From 2005‑2009 there were 87 recalls of infusion pumps (devices including volumetric pumps) to address safety issues: 70 were Class II (less severe), 14 were Class I (highest risk).
  • Many reported adverse events are due to software defects, interface issues, or mechanical/electrical failures in infusion pumps.

VOLUMETRIC PUMPS MARKET REGIONAL INSIGHTS

North America to Grow at the Highest Volumetric Pumps Market Share During the Forecast Period  

With a share, North America led the market for volumetric pumps, and this pattern is anticipated to hold throughout the forecast period. The industry for volumetric pumps has expanded in this area as a result of the rising prevalence of chronic diseases, rising surgical procedures, well-developed and growing R&D, and rising usage of advanced technology in volumetric pumps. Due to the high disease prevalence, high medical R&D expenditure, and a strong healthcare infrastructure, North America dominates the intravenous volumetric pumps market. Diabetes prevalence is also quite high, which is related to their way of living and stressful work environment. 

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio. 

  • BD (Becton, Dickinson and Company): BD held over 50% of the large volume infusion pump market in 2019. Despite a Class I recall of its Alaris™ pumps in 2020, BD maintained a 55%–60% market share in the U.S. infusion pump market as of 2023.
  • Baxter International: Baxter's Novum IQ Large Volume Pump received 510(k) clearance in 2022 and is designed to integrate with hospital electronic medical records. However, in 2025, Baxter paused shipments of the Novum IQ pump after safety incidents, including two reported deaths.

List of Top Volumetric Pumps Companies

  • Alaris (UK.) 
  • Baxter International (U.S.)
  • BD(U.S.)
  • BPL Medical Technologies (India)
  • Cameron Sino (China)
  • CHOSEN SUPPLIES (U.S.)
  • Codan (Australia)
  • Core Lab (Netherlands)
  • Feit (U.S.)
  • Hanna Instruments (Island)
  • Hteco (China)
  • Italtecno Srl. (Italy)
  • KMG (Netherlands)
  • Mighty Max Battery (U.S.)
  • Mindray (China)
  • Nuova Simonelli (Italy)
  • PCM (U.S.)
  • SigmasTek (U.S.)
  • SPS (U.S.)
  • Vermont Flexi Pumps (U.S.)
  • Winequip  (Australia)

REPORT COVERAGE

The market research study examines the worldwide market in detail, focusing on important elements such as leading players, product/services, or type, and leading end-use applications. Aside from that, the research analyses major advancements and provides insights into lighting market trends. In addition to the causes indicated above, the paper includes several other factors that have contributed to recent volumetric pumps market growth in some regions.

Volumetric Pumps Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 3.13 Billion in 2025

Market Size Value By

US$ 5.51 Billion by 2035

Growth Rate

CAGR of 5.8% from 2025 to 2035

Forecast Period

2025-2035

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • JDREX
  • PVM
  • MONO
  • ING

By Application

  • Chemical
  • Industrial
  • Winemaking

FAQs